Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

288
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
288
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

324
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
324
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

509
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
509
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

904
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
904
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.2K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

606
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same author

Diagnostic accuracy and inter-lot precision of the FujiLAM II point-of-care assay to detect tuberculosis in stored urine specimens from people living with HIV.

Microbiology spectrum·2026
Same author

"That is why I trust": a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia.

BMC health services research·2026
Same author

Diagnostic accuracy and potential resource savings of pooled sputum testing with Xpert MTB/RIF Ultra for tuberculosis among adults in Vietnam: a cross-sectional study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Near point-of-care molecular tests for tuberculosis: what will it take to realize their potential?

EClinicalMedicine·2026
Same author

Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy study.

The Lancet. Microbe·2026

Related Experiment Video

Updated: Nov 21, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

A new resource on artificial intelligence powered computer automated detection software products for tuberculosis

Zhi Zhen Qin1, Tasneem Naheyan1, Morten Ruhwald2

  • 1Stop TB Partnership, Chemin Du Pommier 40, Le Grand-Saconnex, Geneva, 1218, Switzerland.

Tuberculosis (Edinburgh, Scotland)
|January 13, 2021
PubMed
Summary

This article introduces a new online resource that helps tuberculosis programs compare different artificial intelligence tools designed to screen for the disease using chest X-rays. By providing detailed information on product features, costs, and technical requirements, the platform assists health officials in selecting the most appropriate technology for their specific needs.

Keywords:
Artificial intelligenceChest X-rayComputer automated detectionDeep learningDiagnosticTuberculosisdigital healthdiagnostic softwareglobal health technologyradiology automation

Frequently Asked Questions

More Related Videos

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K

Related Experiment Videos

Last Updated: Nov 21, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K

Area of Science:

  • Public health informatics and tuberculosis screening research
  • Artificial intelligence powered computer-aided detection software development

Background:

No prior work had resolved the challenge of comparing diverse digital screening tools for respiratory disease. Global health initiatives often struggle with a severe deficit of medical imaging specialists in high-incidence regions. Chest radiography remains a cost-effective strategy for identifying potential cases within vulnerable populations. That uncertainty drove the need for standardized information regarding emerging diagnostic software. Artificial intelligence offers a potential remedy to bridge the gap in clinical expertise. However, stakeholders lack clear guidance on how to evaluate these rapidly evolving digital solutions. This gap motivated the creation of a centralized repository for technical and operational specifications. Prior research has shown that successful adoption depends on more than just raw diagnostic performance metrics.

Purpose Of The Study:

The study aims to provide a comprehensive resource for tuberculosis programs to evaluate and select appropriate digital screening tools. This initiative addresses the challenge of navigating the growing market of automated diagnostic software. The authors seek to bridge the information gap between technology developers and public health implementers. They focus on identifying the specific operational and technical features that influence successful software adoption. By standardizing the presentation of product data, they intend to simplify the procurement process for resource-limited settings. The researchers recognize that diagnostic accuracy alone does not guarantee the effective integration of new technology into clinical workflows. They aim to empower stakeholders with the knowledge required to make evidence-based decisions regarding their screening infrastructure. This effort serves to support the broader goal of improving disease detection rates through the strategic use of innovative digital solutions.

Main Methods:

The research team performed a systematic landscaping analysis to capture the current landscape of diagnostic software. They engaged directly with developers who currently market or plan to release relevant screening tools. Review Approach involved collecting detailed specifications regarding operational, technical, and financial attributes of each product. The investigators verified all gathered information through iterative feedback loops with the original software creators. This collaborative process ensured the accuracy and relevance of the data presented to end-users. They organized the finalized findings into a structured, user-friendly format on a dedicated public website. The methodology included provisions for ongoing maintenance to keep the information current as products evolve. This approach prioritized transparency and accessibility to support informed procurement decisions by public health officials.

Main Results:

The strongest finding is the establishment of a centralized, open-access repository for comparing diverse diagnostic software tools. Key Findings From the Literature indicate that developers provided comprehensive data on operational characteristics and deployment mechanisms. The resource details specific requirements for input formats and machine compatibility across various products. It also outlines essential information regarding integration pathways for existing legacy systems within health facilities. The platform explicitly lists cost structures and data privacy policies for each cataloged tool. It includes information on current certification status to guide regulatory compliance for potential adopters. The authors report that the website serves as a living document to track continuous improvements in the field. This repository provides the first standardized comparison of features for TB-related screening software currently available to the public.

Conclusions:

The authors suggest that their online repository serves as a vital tool for informed decision-making in global health. They propose that TB programs must evaluate operational requirements alongside diagnostic precision when selecting software. The researchers indicate that the platform facilitates a clearer understanding of integration pathways for legacy systems. They highlight that data privacy and cost structures remain significant factors for successful implementation. The team notes that the website will undergo continuous updates to reflect the fast-paced evolution of these technologies. They believe this resource empowers implementers to identify tools that align with their specific programmatic constraints. The authors maintain that transparency regarding certification and deployment mechanisms is necessary for widespread adoption. They conclude that such structured information supports the effective scaling of digital screening interventions worldwide.

The researchers propose that these tools assist in identifying TB-related abnormalities from chest X-rays. By automating the screening process, the software addresses the shortage of skilled radiologists in high-burden regions, thereby improving the efficiency of triage protocols compared to manual interpretation.

The authors developed a comprehensive online resource, available at www.ai4hlth.org, which catalogs various CAD products. This platform provides implementers with detailed information on operational characteristics, deployment mechanisms, and integration options, serving as a centralized hub for comparing different digital solutions.

The researchers emphasize that evaluating integration into legacy systems is necessary for successful deployment. Unlike standalone applications, these systems require compatibility with existing hospital infrastructure to ensure that diagnostic outputs are effectively utilized by clinical staff within established workflows.

The team utilized a landscaping analysis to gather data directly from developers. This approach allowed them to aggregate information on input formats, machine compatibility, and data privacy, which are critical components for assessing the feasibility of adopting new digital tools in diverse settings.

The authors measure success by the ability of programs to identify suitable products based on cost, certification, and operational features. This contrasts with traditional evaluations that focus solely on diagnostic accuracy, highlighting the importance of a holistic assessment framework for digital health interventions.

The researchers propose that this resource enables TB programs to make evidence-based choices. By providing transparent information on available tools, they aim to facilitate the adoption of appropriate technology, ultimately improving the reach and effectiveness of screening interventions in high-burden areas.